基于体积的定量形态学分析在局灶性皮质发育不良中的病灶定位:一项个体水平预实验
本研究回顾性纳入16例经组织学证实的局灶性皮质发育不良患者,采用基于MorphoBox原型的实验性体积形态学算法,将高分辨率T1加权MPRAGE图像分割为45个结构并与年龄性别匹配的正常人群比较。结果显示所有患者均存在体积异常,87.5%(14/16)患者的致痫区位于体积异常结构内,71.4%(10/14)患者的致痫区完全位于萎缩体积区域;最佳z分数截断值为-3.0时,敏感度93.9%、特异度79.6%、ROC曲线下面积0.89。结论认为体积异常可辅助个体水平致痫区诊断,萎缩区较肥大区更可能代表致痫区。
要点
- 87.5%(14/16)患者的致痫区位于体积异常结构内,提示体积分析可辅助定位。
- 71.4%(10/14)患者的致痫区完全位于萎缩体积区域,萎缩区较肥大区更可能代表致痫区。
- 最佳z分数截断值-3.0时,敏感度93.9%、特异度79.6%、AUC 0.89。
核心结论
- 体积异常可辅助常规MRI阴性或阳性局灶性皮质发育不良患者在个体水平诊断致痫区,萎缩区域比肥大区域更可能代表致痫区;基于MorphoBox原型的体积形态学分析有潜力协助放射科医生重点审视萎缩区域,尤其对最初判定为MRI阴性的患者,以期提高局灶性皮质发育不良的检出率。
研究设计与样本
- 回顾性研究纳入16例经组织学证实的局灶性皮质发育不良患者,其中8例常规MRI未见异常、3例异常部分匹配手术切除区域、2例不匹配;采用高分辨率T1加权MPRAGE图像,基于MorphoBox原型按脑解剖模板分割为45个结构,并与年龄性别匹配的正常人群在个体水平比较各结构体积。
关键影像表现/征象
- 所有患者均可见体积异常,包括萎缩性和肥大性体积改变。
- 87.5%(14/16)患者的致痫区位于体积异常脑结构内。
- 71.4%(10/14)患者的致痫区完全位于萎缩体积区域。
诊断标准与关键数值
- 以z分数偏离正常范围评估体积估计值,最佳截断z分数值为-3.0时,体积估计的敏感度93.9%、特异度79.6%、ROC曲线下面积0.89。
临床应用与阅片要点
- 体积形态学分析可辅助在个体水平识别致痫区,尤其对常规MRI阴性患者可重点审视萎缩区域。
- 萎缩区域比肥大区域更可能代表致痫区,阅片时可优先关注萎缩性体积改变。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Surgical resection is the most effective treatment for focal cortical dysplasia (FCD). However, many patients with FCD have unremarkable or even negative findings on conventional magnetic resonance imaging (MRI). In this study, we explored the brain volume abnormalities of FCD patients at the individual level using an experimental volume-based morphometry algorithm and further estimated whether the volume abnormalities can help in the detection of FCD lesions.
MATERIALS AND METHODS: Sixteen patients with histologically-proven FCD lesions were retrospectively studied. Among them, eight patients had no visible abnormalities on routine MRI, three had abnormalities which partly matched the location of the surgical resection regions, and two did not match. For each patient, cerebral high-resolution T1-weighted magnetization-prepared rapid acquisition with gradient echo (MPRAGE) images were segmented into 45 structures, according to a brain anatomy template, and the volume of each structure was compared with an age- and gender-matched normal population at the individual level, based on a MorphoBox prototype. A Receiver Operating Characteristics (ROC) curve was used to evaluate the performance of the prototype in patients. To find the most appropriate threshold value for localizing the epileptogenic zones, deviations from the normative ranges of each resulting volume estimate were assessed by z-scores.
RESULTS: Volume abnormalities including atrophic and hypertrophic volumes could be found in all the patients. Epileptogenic zones were found in brain structures with an abnormal volume in 87.5% (14/16) of patients. In 71.4% of patients (10/14), these zones were fully located in regions with an atrophic volume. This suggests that FCD lesions are more likely to be in regions with an atrophic volume than in those with a hypertrophic volume. When the best cut-off z-score value was -3.0, the sensitivity, specificity, and ROC area under the curve of the volume estimates were 93.9%, 79.6%, and 0.89, respectively.
CONCLUSION: Volume abnormalities can assist in the diagnosis of epileptogenic zones at the individual level in FCD patients with negative or positive findings on conventional MR images. Atrophic regions are more likely than hypertrophic ones to represent epileptogenic zones. Volume-based morphometry based on a MorphoBox prototype has potential to assist a careful scrutiny by radiologists with target in atrophic regions in patients who are initially deemed to be MR-negative, further trying to increase the detection rate of FCD.
引用
- Chen X, Qian T, Maréchal B, et al. Quantitative volume-based morphometry in focal cortical dysplasia: A pilot study for lesion localization at the individual level. Eur J Radiol. 2018. PMID: 30017287. doi:10.1016/j.ejrad.2018.06.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。